Olivia Ware
Director/Board Member at REVANCE THERAPEUTICS, INC.
Net worth: 104 211 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christian Nolet | M | 67 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 5 years |
| Mark Foley | M | 58 | 7 years | |
| Sonja Nelson | F | 51 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 3 years |
| Rami Elghandour | M | 45 | 3 years | |
| Carmine Stengone | M | 48 | 6 years | |
| Dwight Moxie | M | 48 | 4 years | |
| Lori Lyons-Williams | F | 46 | 4 years | |
| Vladimir Coric | M | 53 | 1 years | |
| Paul Maier | M | 76 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
| Tobin Schilke | M | 49 | 6 years | |
| Derek Yoon | M | 49 | 4 years | |
| Kavita Patel | M | 50 | 3 years | |
| Carey Kolaja | F | 51 | 3 years | |
| Daniel Lorrain | M | 55 | 7 years | |
| Julian Gangolli | M | 66 | 8 years | |
| Jill Carroll | F | 48 | 7 years | |
| Jill Beraud | F | 63 | 5 years | |
| Ali Behbahani | M | 48 | 9 years | |
| David Lubner | M | 60 | 4 years | |
| Angus Russell | M | 68 | 13 years | |
| Maryam Abdul-Kareem | F | - | 2 years | |
| Aileen Fernandes | F | - | 3 years | |
| Erica Jordan | F | - | - | |
| Kate Aiken | F | - | 11 years | |
| David Tice | M | 53 | 4 years | |
| Azita Nejad | F | - | 10 years | |
| Jessica Serra | F | - | - | |
| Hong Xia Wang | F | 48 | 3 years | |
| Janice Lu | M | - |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
| Joseph Swedish | M | 72 |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | 6 years |
| Myesha Lacy | F | - | 3 years | |
| Conor Gallagher | M | - | 6 years | |
| Narinder Singh | M | 51 | 3 years | |
| Evert Schimmelpennink | M | 52 | 2 years | |
| Neeraj Teotia | M | 49 | 3 years | |
| David Hollander | M | 50 | 2 years | |
| Michelle Gilson | F | 32 | 2 years | |
| Todd Brady | M | 45 | 5 years | |
| Bradford E. Gliner | M | 58 | 3 years | |
| Christopher Heery | M | 44 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Katrin Rupalla | M | 56 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 2 years |
| Christopher Chai | M | 58 | 7 years | |
| Aubrey Rankin | M | - | 2 years | |
| Dustin Sjuts | M | 45 | 6 years | |
| Martin Babler | M | 59 | 9 years | |
| Neela Paykel | F | 55 |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | 2 years |
| Dan Becker | M | 49 | 3 years | |
| Earl Warren Brien | M | 64 | 5 years | |
| Philip Vickers | M | 64 | 8 years | |
| Lance Thibault | M | 58 | - | |
| Roy C. Hardiman | M | 64 | 5 years | |
| Simeon George | M | 47 | 9 years | |
| Joseph Rubinfeld | M | 91 | 14 years | |
| Alan Colowick | M | 61 | 3 years | |
| Robert F. Byrnes | M | 79 | 17 years | |
| Lewis Williams | M | 74 | 3 years | |
| Cheryl Cohen | F | 58 | 1 years | |
| Benjamin S. Levin | M | 46 | 12 years | |
| Phyllis Gardner | M | 73 | 15 years | |
| Abhay Joshi | M | 61 | 7 years | |
| Stefani Wolff | F | 62 | 4 years | |
| Sara Fahy | F | - | - | |
| Taryn Conway | F | - | 3 years | |
| Dolca Thomas | M | 53 | 2 years | |
| Michael Dombeck | M | - | - | |
| Clarence Machado | M | 60 | 1 years | |
| Shao Lee Lin | M | 57 | 1 years | |
| Simon Allen | M | 56 |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | 3 years |
| Justin Ford | M | - | 6 years | |
| Roman Rubio | M | 53 | 5 years | |
| Michael Byrnes | M | 47 | - | |
| Shawn Tomasello | F | 65 | 1 years | |
| Marc Korenberg | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 93.15% |
| Cayman Islands | 6 | 8.22% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Olivia Ware
- Personal Network
